Vitoc Vlad

Chief Executive Officer, Director, 10% OwnerMAIA Biotechnology, Inc. (MAIA) · full profile →Form 4 · filed Nov 7, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
0 non-derivative · 12 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 5, 2024Gift(G)41K$2.50$103K41K
Nov 5, 2024Gift(G)41K$2.50$103K0
Nov 5, 2024Gift(G)41K$2.50$103K41K
Nov 5, 2024Gift(G)41K$2.50$103K41K
Nov 5, 2024Gift(G)41K$2.50$103K41K
Nov 5, 2024Gift(G)41K$2.50$103K83K
Nov 5, 2024Gift(G)20K$1.80$36K110K
Nov 5, 2024Gift(G)20K$1.80$36K20K
Nov 5, 2024Gift(G)20K$1.80$36K130K
Nov 5, 2024Gift(G)20K$1.80$36K20K
Nov 5, 2024Gift(G)20K$1.80$36K150K
Nov 5, 2024Gift(G)20K$1.80$36K20K

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-24-026731) within minutes of acceptance. Every field above traces to the original document. Verify it directly: